Aurobindo Pharma shares will remain in focus after the US FDA completed an inspection of its Unit-V facility, with two procedural observations. The company will respond within the stipulated time. In ...
Yesterday’ PMI data showed a mixed bag. Manufacturing data from France, Germany, the UK and US have been weaker while the services sector continues to show upside momentum, similarly to recent ...